HTG Molecular Diagnostics
HTGM
#9998
Rank
NZ$1.77 M
Marketcap
$0.80
Share price
0.00%
Change (1 day)
-96.31%
Change (1 year)

P/E ratio for HTG Molecular Diagnostics (HTGM)

P/E ratio on August 17, 2023 (TTM): -0.0169

According to HTG Molecular Diagnostics 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.0169492. At the end of 2017 the company had a P/E ratio of -1.05.

P/E ratio history for HTG Molecular Diagnostics from 2015 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2017-1.0571.91%
2016-0.6087155.62%
2015-0.2381

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-4.80 28,201.51%๐Ÿ‡ฉ๐Ÿ‡ช Germany
-0.0007-95.65%๐Ÿ‡บ๐Ÿ‡ธ USA
-1.81 10,572.01%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.